OnDemand WTP Pricing Research

Tag: Health Services Pricing

Report highlights significant variation in healthcare costs | Augusta Free Press

Report highlights significant variation in healthcare costs | Augusta Free Press

Unlike insurers and employers, those without health insurance have very little information to help to negotiate costs.  On VHI’s website, consumers can gain leverage by using the average amount health insurance companies approve.  “With the release of the 2016 Healthcare Pricing Transparency report, VHI continues to serve as an unbiased resource for consumers trying to […]

Trump Promises Lower Drug Prices, but Drops Populist Solutions | The New York Times

Trump Promises Lower Drug Prices, but Drops Populist Solutions | The New York Times

WASHINGTON — President Trump vowed on Friday to “bring soaring drug prices back down to earth” by promoting competition among pharmaceutical companies, and he suggested that the government could require drugmakers to disclose prices in their ubiquitous television advertising. But he dropped the popular and populist proposals of his presidential campaign, opting not to have […]

Pricing Lessons from the Pharmaceutical Industry | Strategic Pricing Solutions

Pricing Lessons from the Pharmaceutical Industry | Strategic Pricing Solutions

Over the past several months, pricing strategies and practices of the pharmaceutical industry have been a subject of discussion, many times for the wrong reasons.  In particular, Valeant has come under extreme criticism for raising the prices of its drugs.  Another company, Turing Pharmaceuticals raised the price of Daraprim from $13.50 to $750.00, an increase […]

Paper: Toward Value-Based Pricing to Boost Cancer Research and Innovation | Cancer Research

Paper: Toward Value-Based Pricing to Boost Cancer Research and Innovation | Cancer Research

Abstract The high market price of new anticancer agents has stimulated debate about the long-term sustainability of healthcare systems and whether these new agents can continue to be supported by public healthcare or by private insurers. In addition, some drugs have been approved with limited clinical benefit, raising concerns about setting a minimum requirement for […]